1. 1. American Thoracic Society Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Resp Crit Care Med (Supplement) 1995; 152 (5): S78-S100. 2. Honig EG, Ingram RH. Chronic bronchitis, emphysema, and airways obstruction. In Fauci AS, Braunwald E, Isselbacher KJ, et al. (editors). Harrison’s Principles of Internal Medicine. 14th Ed. New York: McGraw-Hill, 1998. 1451-1457. 3. Kobzik L, Schoen FJ. The Lung. In Cotran RS, Kumar V, Robbins SL. Robbins Pathologic Basis of Disease 2nd Ed. Philadelphia: W.B. Saunders Co., 1994. 683-689. 4. Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Eng J Med 1993; 328: 1017-1022. 5. Postma DS. Inhaled therapy in COPD: What are the benefits? Respir Med 1991; 85: 447-449. 6. Nisar M, Earis JE, Pearson MG, et al. Acute bronchodilator trials in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146: 555-559. 7. Karpel JP. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD. Chest 1991; 99: 871-876. 8. Karpel JP, Kotch A, Zinny J, et al. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD. Chest 1994; 105: 1089-1094. 9. Sullivan P, Bekir S, Jaffar Z, et al. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343: 1006-1008. 10. Hudson LD, Monti CM. Rationale and use of corticosteroids in chronic obstructive pulmonary disease. Med Clin N Am 1990; 74: 661-690. 11. Niewoehner DE, Erbland ML, Deupree RH, et al. for the Department of Veterans Affairs Cooperative Study Group. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Eng J Med 1999; 340: 1941-1947.